Brokers Issue Forecasts for VRTX Q1 Earnings
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of Vertex Pharmaceuticals in a note issued to investors on Monday, February 10th. Leerink Partnrs analyst D. Risinger expects that the pharmaceutical company will post earnings of $3.50 per share for […]
